Rewiring the solid tumor epigenome for cancer therapy.

Area of Science:

• Oncology
• Epigenetics
• Cancer Biology

Background:

• Epigenetic alterations are a key hallmark of cancer, alongside genetic mutations.
• Understanding epigenetic regulation is crucial for cancer therapy development.

Purpose of the Study:

• To explain epigenetic regulation and therapy principles.
• To review approved epigenetic drugs, novel targets, and combination treatments.
• To discuss factors influencing epigenetic cancer therapy success and failure.

Main Methods:

• Review of epigenetic regulation and cancer pathways.
• Analysis of clinical trial data for epigenetic drugs.
• Exploration of novel pharmaceutical targets and compounds.
• Discussion of biological factors affecting treatment outcomes.

Main Results:

• Early epigenetic therapy trials faced challenges but provided valuable lessons.
• Modern trial designs, informed by past experiences, show improved therapeutic outcomes.
• Novel targets and combination treatments are emerging in epigenetic cancer therapy.

Conclusions:

• Epigenetic therapy is a vital component of cancer treatment.
• Lessons from past trials are improving current and future therapeutic strategies.
• Advanced preclinical models are essential for identifying reliable targets and reducing clinical failure risk.